{
    "pmid": "41465549",
    "title": "Immunopathogenic Mechanisms in Connective Tissue Disease-Associated Interstitial Lung Disease: Incessant Loop of Immunity to Fibrosis.",
    "abstract": "Connective tissue disease-associated interstitial lung disease (CTD-ILD) represents a significant cause of morbidity and mortality. It is characterized by the progressive convergence of chronic inflammation, immune dysregulation, and fibrotic remodeling in the lung parenchyma. While often conceptualized through a model of idiopathic pulmonary fibrosis (IPF), CTD-ILD is fundamentally an immune-driven pathology with distinct inflammatory mechanisms in which adaptive immunity plays a profound role. This narrative review explores the \"inflammation-immunity-fibrosis continuum\" in CTD-ILD, elaborating the intricate cellular and molecular pathways that distinguish it from IPF. We highlight the central role of persistent T-cell responses and B-cell dysregulation, which often occur within organized tertiary lymphoid structures in the lung. This review examines how these immune processes are propagated by multiple cytokine pathways, including the TGF-Î²/SMAD, JAK/STAT, and phosphodiesterase-4 signaling pathways, which serve as crucial links between inflammation and fibrosis. This distinct immune mechanism in CTD-ILD explains why immunomodulatory agents are a cornerstone of CTD-ILD treatment, in contrast to their limited efficacy in IPF, and emphasizes the current paradigm of combining immunosuppression with antifibrotic drugs to target the dual drivers of the disease.",
    "disease": "rheumatoid arthritis",
    "clean_text": "immunopathogenic mechanisms in connective tissue disease associated interstitial lung disease incessant loop of immunity to fibrosis connective tissue disease associated interstitial lung disease ctd ild represents a significant cause of morbidity and mortality it is characterized by the progressive convergence of chronic inflammation immune dysregulation and fibrotic remodeling in the lung parenchyma while often conceptualized through a model of idiopathic pulmonary fibrosis ipf ctd ild is fundamentally an immune driven pathology with distinct inflammatory mechanisms in which adaptive immunity plays a profound role this narrative review explores the inflammation immunity fibrosis continuum in ctd ild elaborating the intricate cellular and molecular pathways that distinguish it from ipf we highlight the central role of persistent t cell responses and b cell dysregulation which often occur within organized tertiary lymphoid structures in the lung this review examines how these immune processes are propagated by multiple cytokine pathways including the tgf smad jak stat and phosphodiesterase signaling pathways which serve as crucial links between inflammation and fibrosis this distinct immune mechanism in ctd ild explains why immunomodulatory agents are a cornerstone of ctd ild treatment in contrast to their limited efficacy in ipf and emphasizes the current paradigm of combining immunosuppression with antifibrotic drugs to target the dual drivers of the disease"
}